Evidence map›Paper›PMID 38396676›Full record

ArticleInternational journal of molecular sciences2024

New Derivatives of 1-(3-Methyl-1-Benzofuran-2-yl)Ethan-1-one: Synthesis and Preliminary Studies of Biological Activity.

Mariola Napiórkowska, Pratheeba Kumaravel, Mithulya Amboo Mahentheran, Ewelina Kiernozek-Kalińska, Emilia Grosicka-Maciąg

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Special Issue "Development and Synthesis of Biologically Active Compounds".International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Mariola NapiórkowskaChair and Department of Biochemistry, Medical University of Warsaw, 1 Banacha Str., 02-097 Warsaw, Poland.
Pratheeba KumaravelChair and Department of Biochemistry, Medical University of Warsaw, 1 Banacha Str., 02-097 Warsaw, Poland.
Mithulya Amboo MahentheranChair and Department of Biochemistry, Medical University of Warsaw, 1 Banacha Str., 02-097 Warsaw, Poland.ORCID 0009-0006-9848-4972
Ewelina Kiernozek-KalińskaDepartment of Immunology, Faculty of Biology, University of Warsaw, 1 Miecznikowa Str., 02-096 Warsaw, Poland.
Emilia Grosicka-MaciągDepartment of Biochemistry and Laboratory Diagnostic, Collegium Medicum Cardinal Stefan Wyszyński University, Kazimierza Wóycickiego 1 Str., 01-938 Warsaw, Poland.ORCID 0000-0003-1318-1018
Medical University of Warsaw · PLCardinal Stefan Wyszynski University in Warsaw · PLUniversity of Warsaw · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A set of nine derivatives, including five brominated compounds, was synthesized and the structures of these novel compounds were confirmed using

Indexed as

Antineoplastic AgentsBenzofuransInterleukin-6ApoptosisCell Line, TumorCell ProliferationDrug Screening Assays, AntitumorHumansK562 CellsReactive Oxygen Species1-benzofuranAntineoplastic AgentsBenzofuransInterleukin-6Reactive Oxygen Speciesantibacterialanticancerapoptosisbenzofuranscytotoxicitysynthesis

Identifiers

PMID38396676
PMCPMC10888192
OpenAlexW4391606030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.